Latest filing published 18 Sept 2026 for AstraZeneca PLC, €8.5M. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Pascal Soriot is a declared insider of AstraZeneca PLC, with filings sourced from Finansinspektionen. The record holds 19 filings, for trades running from 20 February 2024 to 14 September 2026.
On the market, this insider has only ever bought: 11 purchases, €10.9M in total. The amount is not disclosed for 9 filings. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 6 share grants. Since January 2026: 4 purchases and no sales on the market.
Clusters matter here: 1 out of 11 purchases overlapped with buying by a colleague within 30 days. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time.
Most recently, on 18 September 2026, the filings show an open-market purchase worth €8.5M in AstraZeneca PLC. Typically, a trade is published a median of 2 days after it takes place. The regulation allows three business days to notify a trade (MAR article 19). This summary is built from Finansinspektionen disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
19 of 19 declarations